rs10887668

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004329.3(BMPR1A):​c.530+2333A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 151,950 control chromosomes in the GnomAD database, including 6,067 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 6067 hom., cov: 31)

Consequence

BMPR1A
NM_004329.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.347

Publications

8 publications found
Variant links:
Genes affected
BMPR1A (HGNC:1076): (bone morphogenetic protein receptor type 1A) The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. [provided by RefSeq, Jul 2008]
BMPR1A Gene-Disease associations (from GenCC):
  • generalized juvenile polyposis/juvenile polyposis coli
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Genomics England PanelApp
  • juvenile polyposis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • polyposis syndrome, hereditary mixed, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • hereditary mixed polyposis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital heart defects, multiple types
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • pulmonary arterial hypertension
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.496 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BMPR1ANM_004329.3 linkc.530+2333A>C intron_variant Intron 7 of 12 ENST00000372037.8 NP_004320.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BMPR1AENST00000372037.8 linkc.530+2333A>C intron_variant Intron 7 of 12 1 NM_004329.3 ENSP00000361107.2

Frequencies

GnomAD3 genomes
AF:
0.219
AC:
33268
AN:
151834
Hom.:
6043
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.501
Gnomad AMI
AF:
0.154
Gnomad AMR
AF:
0.124
Gnomad ASJ
AF:
0.125
Gnomad EAS
AF:
0.0370
Gnomad SAS
AF:
0.152
Gnomad FIN
AF:
0.141
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.107
Gnomad OTH
AF:
0.200
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.219
AC:
33336
AN:
151950
Hom.:
6067
Cov.:
31
AF XY:
0.216
AC XY:
16042
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.501
AC:
20732
AN:
41358
American (AMR)
AF:
0.124
AC:
1892
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
433
AN:
3470
East Asian (EAS)
AF:
0.0371
AC:
192
AN:
5174
South Asian (SAS)
AF:
0.151
AC:
727
AN:
4804
European-Finnish (FIN)
AF:
0.141
AC:
1484
AN:
10554
Middle Eastern (MID)
AF:
0.156
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
0.107
AC:
7272
AN:
67996
Other (OTH)
AF:
0.198
AC:
418
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1064
2128
3192
4256
5320
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
308
616
924
1232
1540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.149
Hom.:
7300
Bravo
AF:
0.231
Asia WGS
AF:
0.129
AC:
453
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
2.6
DANN
Benign
0.49
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10887668; hg19: chr10-88662216; API